Pharmaceutical

AstraZeneca CEO calls for increased European investment in pharma

CEO Soriot said Europe must boost investment in pharma innovation or risk falling further behind the US in drug development.

Apr 30, 2025 - 06:00
AstraZeneca CEO calls for increased European investment in pharma
CEO Soriot said Europe must boost investment in pharma innovation or risk falling further behind the US in drug development.
Read the original article

Tags:

Previous Article

Myostatin inhibitors target muscle loss prevention to fill gap in GLP-1RA market

Next Article

Small biotechs shoulder the burdens of an uncertain biopharma sector

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

United Laboratories International sees highest patent f...

Dec 10, 2023

How the GLP-1 receptor agonist market could hit $168bn by 2033

How the GLP-1 receptor agonist market could hit $168bn ...

Aug 11, 2024

STAT+: As the obesity drug market grows, digital health companies juggle patients and payers

STAT+: As the obesity drug market grows, digital health...

Aug 21, 2023